Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

NCT02434614 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

440

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Docetaxel,Cisplatin,Fluorouracil
RADIATION: Intensity-modulated radiation therapy (IMRT)
DRUG: Cisplatin

Sponsor

Wei Jiang

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]